Nalaganje...
On the Regulatory Approval Pathway of Biosimilar Products
Biosimilars (or follow-on biologics) are a new class of medicine which enters the market subsequent to a previously approved version. They have demonstrated similarity to innovator biologic products in terms of quality, safety, and efficacy. The EMA has taken the lead in the regulatory approval fram...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2012
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3763644/ https://ncbi.nlm.nih.gov/pubmed/24281406 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph5040353 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|